Focus Partners Advisor Solutions, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1868872
SAINT LOUIS, MO
Position in NBIX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,927,086
-$525,649 QoQ
Shares Held
11,434
-38.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#318
of 768 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Focus Partners Advisor Solutions, LLC holds $5,018,095 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (38.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
11,434 | $1,927,086 | |
| 2 | VTRS |
Viatris Inc
|
88,753 | $1,409,397 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,467 | $794,864 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,587 | $324,807 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
14,302 | $229,261 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
13,190 | $191,123 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
33,624 | $141,557 |
All Filings in NBIX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,927,086 | 11,434 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $2,452,735 | 18,618 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $2,062,775 | 14,544 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $1,861,859 | 13,263 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $660,123 | 5,252 | Shares | Other | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||